Literature DB >> 310855

Characterization of lipopolysaccharide of Haemophilus influenzae.

A R Flesher, R A Insel.   

Abstract

Lipopolysaccharide from strains of Haemophilus influenzae was extracted and isolated by the hot phenol-water procedure. The preparations were relatively insoluble in water but could be solubilized with surface-active agents. The preparations contained carbohydrate (30%), fatty acid (29%), and phosphate (4.7%); protein content was less than 1%. Thin-layer chromatography, gas-liquid chromatography, and colorimetric assays detected glucose, galactose, glucosamine, heptose, and a 2-keto-3-deoxy-octonate-like molecule (less than 1%). Neither methylpentose nor dideoxyhexose was detected. The lipid portion was composed of fatty acids common to lipopolysaccharide of Salmonella. The preparations provoked positive dermal Shwartzman reactions and biphasic febrile responses in rabbits, responses typical of endotoxic activity. The 50% lethal dose for mice was decreased from 16.5 microgram/g to 0.015 microgram/g by concomitant administration of actinomycin D. The preparations were shown to be polyclonal activators of bone marrow-derived (B) cells. Limulus lysate gelation was seen with 8.0 ng of lipopolysaccharide. Preliminary hemagglutination data suggested at least three different antigenic factors associated with the lipopolysaccharide of H. influenzae type b. The H. influenzae lipopolysaccharide appeared biologically similar to that of enterobacteria but chemically different.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310855     DOI: 10.1093/infdis/138.6.719

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Inactivation of Haemophilus influenzae lipopolysaccharide biosynthesis genes interferes with outer membrane localization of the hap autotransporter.

Authors:  Nicole A Spahich; Derek W Hood; E Richard Moxon; Joseph W St Geme
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

2.  Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b.

Authors:  P A Gulig; C C Patrick; L Hermanstorfer; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.

Authors:  J N Weiser; A Williams; E R Moxon
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b.

Authors:  C C Patrick; S E Pelzel; E E Miller; E Haanes-Fritz; J D Radolf; P A Gulig; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Identification of phosphorylated 3-deoxy-manno-octulosonic acid as a component of Haemophilus influenzae lipopolysaccharide.

Authors:  S E Zamze; M A Ferguson; E R Moxon; R A Dwek; T W Rademacher
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

7.  Legionella pneumophila and limulus endotoxin assay: recent findings.

Authors:  D Fumarola
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Antigenic heterogeneity of lipid A of Haemophilus influenzae.

Authors:  M A Apicella; K C Dudas; A Campagnari; P Rice; J M Mylotte; T F Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

10.  Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.

Authors:  G B Toews; S Viroslav; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.